Top of page
Advertise with us
Technology

FDA approves digital therapeutic game for kids with ADHD

kid playing game with smartphone

The U.S. Food and Drug Administration has approved the first video game designed as a “digital therapeutic” treatment for kids with Attention Deficity Hyperactivity Disorder (ADHD).

US health officials have approved the first game-based treatment for children with attention deficit hyperactivity disorder, part of a trend toward “digital therapeutics” or software to address certain conditions.

The Food and Drug Administration said Monday it approved the sale by prescription of the game EndeavorRX from health tech startup Akili Interactive for children aged 8-12 who have been diagnosed with ADHD.

The FDA said this was the first digital therapeutic intended to treat ADHD, as well as the first game-based therapeutic approved for any type of condition.

The game, designed to improve cognitive function, is designed as part of a program that may also include other kinds of therapy, medication, and educational programs.

“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren, director of the FDA Center for Devices and Radiological Health.

Digital therapeutics have been approved for certain treatments such as addiction disorders and are being testing for a range of other conditions from chronic pain to anxiety.

EndeavorRX allows children to control cartoon-like characters on a type of hoverboard and is designed to target and activate neural systems through sensory stimuli and motor challenges to improve cognitive functioning.

“We’re proud to make history today with FDA’s decision,” said Eddie Martucci, chief executive officer of Akili.

“With EndeavorRx, we’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.”

The approval of EndeavorRx followed studies of some 600 children diagnosed with ADHD.

The company said the research found that after four weeks of EndeavorRx treatment, one-third of children no longer had a measurable attention deficit on at least one measure of objective attention and that about half of parents saw a meaningful change in their child’s day-to-day impairments after one month of treatment with EndeavorRx.

You might also like

Prosthesis on the arm of a boy

Researchers design robotic arm to help people with disabilities operate devices

A research team at the Indian Institute of Science (IISc)…

Cyborg hand holding devices with medical iconnd stethoscope 3d rendering

AI to better diagnose and treat neurological and mental health disabilities

The University of Sydney has been awarded more than $7…

A happy small girl with tablet at home.

Researchers to develop remote e-learning platform for children with autism

A team of researchers led by a Qatari professor is…

a woman using the Disability in the Bush app

Disability App to bridge information gap among Indigenous Australian communities

A new disability app providing accessible and culturally contextual information…